Document Detail


Myocardial response to stress in cardiac hypertrophy and heart failure: effect of antihypertensive drugs.
MedLine Citation:
PMID:  10415526     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The myocardium's response to increased stress or load is not stereotyped. Differences have been observed in the heart's molecular composition and performance characteristics when exposed to stress. Myosin isoforms gradually change during development of hypertrophy, whereas collagen levels change only during the chronic phase of hypertrophy. Cardiac hypertrophy can regress if treated with antihypertensive drugs, but the myocardium of the post-hypertrophic heart no longer has the same composition as it did before hypertrophy. In rat studies of the effects of antihypertensive drugs on cardiac functional reserve, captopril showed a regression of hypertrophy associated with a lower baseline stroke volume and, after dobutamine stress, a dose-dependent rise in stroke volume. In untreated rates captopril showed no change in stroke volume. In hydralazine-treated rats, there was no change in reserve after dobutamine stress, whereas propranolol treatment resulted in partial regression and a slight change in stroke volume. Overall, our data suggests that development of hypertension and hypertrophy plays a role in changes in the molecular structure of the myocardium, especially during the chronic phase of hypertrophy and heart failure. This complex process cannot be explained by one factor but involves a combination of factors. Identification of each factor would be of importance for the development of appropriate therapeutic agents.
Authors:
S Sen
Related Documents :
6226196 - Clinical determinants and consequences of left ventricular hypertrophy.
18762556 - Biochemical markers of myocardial remodelling in hypertensive heart disease.
11565366 - The rational approach to the electrical exploration of the heart.
9227526 - Physiological assessment of complex cardiac phenotypes in genetically engineered mice.
12969516 - Brachial-ankle pulse wave velocity and symptomatic cerebral infarction in patients with...
3761566 - Myocardial ischemia stimulates catecholamine synthesis and catabolism in the dog adrena...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Annals of the New York Academy of Sciences     Volume:  874     ISSN:  0077-8923     ISO Abbreviation:  Ann. N. Y. Acad. Sci.     Publication Date:  1999 Jun 
Date Detail:
Created Date:  1999-08-03     Completed Date:  1999-08-03     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7506858     Medline TA:  Ann N Y Acad Sci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  125-33     Citation Subset:  IM    
Affiliation:
Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation, Ohio 44195, USA. sens@cesmtp.ccf.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antihypertensive Agents / pharmacology*
Cardiac Output, Low / physiopathology*
Cardiomegaly / physiopathology*
Cardiotonic Agents / pharmacology
Collagen / metabolism
Disease Progression
Dobutamine / pharmacology
Heart / drug effects*,  physiopathology*
Male
Myocardium / enzymology
Myosins / metabolism
Protein Isoforms / metabolism
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Stress, Mechanical
Grant Support
ID/Acronym/Agency:
R01 HL27838/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Cardiotonic Agents; 0/Protein Isoforms; 34368-04-2/Dobutamine; 9007-34-5/Collagen; EC 3.6.4.1/Myosins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vitro analysis of SERCA2 gene regulation in hypertrophic cardiomyocytes and increasing transfecti...
Next Document:  Oxidized LDL and atherogenesis.